| $385M | ||
| $350M | ||
| $215M | ||
| $94M | ||
| $82M | ||
| $62M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
Over the last 12 months, insiders at Genprex, Inc. have bought $0 and sold $0 worth of Genprex, Inc. stock.
On average, over the past 5 years, insiders at Genprex, Inc. have bought $51,887 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,000 shares for transaction amount of $21,478 was made by VACZY CATHERINE M (EVP GC Chief Strategy Officer) on 2023‑04‑21.
| 2023-04-21 | VACZY CATHERINE M | EVP GC Chief Strategy Officer | 20,000 0.0426% | $1.07 | $21,478 | -70.00% | ||
| 2023-04-21 | Varner John Rodney | Chairman, President and CEO | 19,000 0.0398% | $1.05 | $20,045 | -70.00% | ||
| 2021-04-05 | LONGNECKER BRENT M | director | 15,000 0.0313% | $4.15 | $62,250 | -37.14% | ||
| 2019-09-05 | Varner John Rodney | Chief Executive Officer | 1,800 0.0116% | $0.89 | $1,595 | +158.62% | ||
| 2018-07-30 | Pham Julien L | President & COO | 500 0.0038% | $3.40 | $1,700 | -47.75% | ||
| 2018-03-29 | ROTH JACK A | 10 percent owner | 40,000 0.3625% | $5.00 | $200,000 | -53.19% | ||
| 2018-03-29 | Varner John Rodney | Chief Executive Officer | 10,000 0.0906% | $5.00 | $50,000 | -53.19% | ||
| 2018-03-29 | Nance Christy M. | 10 percent owner | 50,000 0.4531% | $5.00 | $250,000 | -53.19% |
| Increased Positions | 8 | +32% | 18,147 | +135.37% |
| Decreased Positions | 9 | -36% | 2,043 | -15.24% |
| New Positions | <1 | New | 4,104 | New |
| Sold Out Positions | 6 | Sold Out | 1,907 | Sold Out |
| Total Postitions | 24 | -4% | 29,509 | +120.13% |
| Vanguard Group Inc | $16.00 | 0.43% | 8,667 | +8,361 | +2,732.35% | 2025-09-30 |
| Susquehanna International Group, Llp | $12.00 | 0.34% | 6,801 | +713 | +11.71% | 2025-09-30 |
| Jane Street Group, Llc | $7.00 | 0.21% | 4,104 | +4,104 | New | 2025-09-30 |
| Geode Capital Management, Llc | $6.00 | 0.16% | 3,281 | +1,777 | +118.15% | 2025-09-30 |
| Ubs Group Ag | $6.00 | 0.16% | 3,244 | +619 | +23.58% | 2025-09-30 |
| Sbi Securities Co., Ltd. | $4.00 | 0.12% | 2,421 | +2,373 | +4,943.75% | 2025-09-30 |
| Hub Investment Partners, Llc | $1.00 | 0.02% | 340 | +30 | +9.68% | 2025-09-30 |
| Blackrock, Inc. | $0 | 0.01% | 188 | -2 | -1.05% | 2025-09-30 |
| Osaic Holdings, Inc. | $0 | 0.01% | 172 | +170 | +8,500% | 2025-09-30 |
| Citigroup Inc | $0 | 0.01% | 122 | -130 | -51.59% | 2025-09-30 |